Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shares traded up 3.3% during mid-day trading on Friday . The stock traded as high as $11.60 and last traded at $11.32. 1,268,100 shares were traded during mid-day trading, an increase of 275% from the average session volume of 337,931 shares. The stock had previously closed at $10.96.
Silverback Therapeutics Trading Up 3.3 %
The stock has a market cap of $408.18 million, a PE ratio of -4.68 and a beta of 0.60. The business has a 50-day moving average price of $14.25 and a 200 day moving average price of $12.31.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
